CRL
HOLD / NEUTRALMeanRevComposite
51.70
Technical
90.40
Fundamental
38.80
Rank
—
Price
260.72
Hurst
0.32
As of
Aug 6, 2026
Daily
Charles River Laboratories International, Inc.
HealthcareDiagnostics & ResearchCharles River Laboratories International, Inc. operates across multiple segments serving the pharmaceutical and biotechnology industries worldwide. The company breeds laboratory animals for research purposes, conducts preclinical drug testing and safety assessments including toxicology and pharmacokinetics studies, and provides contract manufacturing and quality control services for pharmaceutical and consumer products. Additionally, the firm develops cell therapies and maintains collaborative partnerships focused on cancer immunotherapy and vaccine development.
Market cap
$17.3B
P/E (trailing)
—
P/E (forward)
28.20
PEG ratio
0.12
Dividend yield
0.00%
Beta
1.40
52w range
146.20 – 379.63
Return on equity
-7.52%
Profit margin
-5.96%
Revenue growth
-2.70%
Earnings growth
—
Price history
1Y: 359.41 (+99.6%) · range 149.93–376.10
Cycle position
86/ 100 cycle scoreEXIT ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 0 · NOT READY · exit proximity 55
Conviction
21/ 100 · maturity 57%
VScore.2818
Buildup.2435
EMA entry setup.300
Fundamentals.1839
Volume profile
POC
279.26
Price vs POC
+28.7%
Overhead supply
3%
Runway
open sky
Value area 220.90–379.63 · 3% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| trend-signal | 0.186 | Oct 22, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +1.68% | +1.68% | 1/20d |
| 40d | +1.68% | +1.68% | 1/40d |